Showing 1 - 10 of 6,693
Persistent link: https://www.econbiz.de/10009124913
Persistent link: https://www.econbiz.de/10011999628
Persistent link: https://www.econbiz.de/10000637384
Persistent link: https://www.econbiz.de/10008826540
were introduced in Germany in 1997 to reduce moral hazard and public health expenditures in the market for convalescent …
Persistent link: https://www.econbiz.de/10008826715
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years …. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both …
Persistent link: https://www.econbiz.de/10009492625
Persistent link: https://www.econbiz.de/10011549220
Persistent link: https://www.econbiz.de/10010478974
were introduced in Germany in 1997 to reduce moral hazard and public health expenditures in the market for convalescent …
Persistent link: https://www.econbiz.de/10009235125